Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Qingdao Baheal Medical INC.

Market Cap 1.05TCr 154.84Cr 134.37Cr 123.86Cr 116.06Cr 216.84Cr 15TCr 221.36Cr 1.48TCr 572.04Cr 7.15TCr 581.27Cr 568.74Cr 25TCr P/E Ratio 2026 *
19.4x
P/E Ratio 2027 * 14.1x
Enterprise Value 1.05TCr 154.84Cr 134.37Cr 123.86Cr 116.06Cr 216.84Cr 15TCr 221.36Cr 1.48TCr 572.04Cr 7.15TCr 581.27Cr 568.74Cr 25TCr EV / Sales 2026 *
1.37x
EV / Sales 2027 * 1.24x
Free-Float
24.89%
Yield 2026 *
-
Yield 2027 * -
29/04 Qingdao Baheal Medical INC. announces Annual dividend, payable on June 01, 2026 CI
28/04 Qingdao Baheal Medical INC. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
28/04 Qingdao Baheal Medical INC. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/04 SicaGene Biotechnology Co., Ltd announced that it has received CNY 43 million in funding from Qingdao Baheal Medical INC. and another investor CI
02/04 SicaGene Biotechnology Co., Ltd announced that it has received CNY 27 million in funding from Qingdao Baheal Medical INC., Beijing Baheal Zhongxin Health Investment Management Co., Ltd. and other investors CI
31/12 Beijing Baiyangjia Health Management Co., Ltd. completed the acquisition of 40.05% stake in Beijing We-health Technology CO., Ltd. from Qingdao Baheal Medical INC.. CI
12/12 Qingdao Baheal Medical INC.(SZSE:301015) dropped from Shenzhen Stock Exchange Component A Share Index CI
12/12 Qingdao Baheal Medical INC.(SZSE:301015) dropped from Shenzhen Stock Exchange Component Index CI
29/25/29 Qingdao Baheal Medical INC. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
29/25/29 Beijing Baiyangjia Health Management Co., Ltd. agreed to acquire 40.05% stake in Beijing We-health Technology CO., Ltd. from Qingdao Baheal Medical INC. for CNY 57.5 million. CI
19/25/19 Qingdao Baheal Medical INC. Approves Board Elections CI
28/25/28 Qingdao Baheal Medical INC. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
13/25/13 CANbridge Pharmaceuticals Attracts HK$98 Million Investment From Qingdao Baheal; Shares Jump 34% MT
1 day-2.30%
1 week-3.71%
Current month-10.81%
1 month-18.03%
3 months-9.93%
6 months-13.48%
Current year-15.42%
1 week 19.7
Extreme 19.7
21.13
1 month 19.7
Extreme 19.7
24.03
Current year 19.7
Extreme 19.7
28.77
1 year 19
Extreme 19
32.38
3 years 17.37
Extreme 17.37
43.5
5 years 17.37
Extreme 17.37
56.16
10 years 17.37
Extreme 17.37
56.16
Manager TitleAgeSince
Corporate Officer/Principal 63 01/12/2005
Chief Executive Officer 56 01/01/2016
Director of Finance/CFO 55 26/05/2020
Director TitleAgeSince
Director/Board Member 76 04/08/2022
Director/Board Member 61 04/08/2022
Director/Board Member 64 04/08/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.30%-3.71%-14.30%-30.21% 154.84Cr
-0.41%+3.99%+9.67%+99.84% 9.46TCr
+2.25%+9.63%+44.05%+154.88% 5.18TCr
-0.93%-8.73%-17.24%+217.26% 2.16TCr
-0.06%+0.87%-12.36%-30.00% 804.81Cr
+1.78%+4.63%-32.88%-26.99% 753.96Cr
+0.54%-1.63%-11.64%-36.59% 668.98Cr
+0.58%+0.36%+13.54%+23.38% 662.93Cr
-0.24%+1.68%-1.11%+18.54% 527.57Cr
+0.21%-4.44%-12.08%-18.67% 348.09Cr
Average +0.16%+0.22%-3.43%+37.14% 2.07TCr
Weighted average by Cap. +0.36%+4.93%+11.67%+104.32%

Financials

2026 *2027 *
Net sales 767Cr 113.2Cr 98Cr 91Cr 85Cr 158.53Cr 11TCr 161.83Cr 1.08TCr 418.2Cr 5.22TCr 424.95Cr 415.79Cr 18TCr 843.57Cr 124.5Cr 108.04Cr 100Cr 93Cr 174.35Cr 12TCr 177.98Cr 1.19TCr 459.95Cr 5.75TCr 467.37Cr 457.3Cr 20TCr
Net income 54Cr 7.99Cr 6.93Cr 6.39Cr 5.99Cr 11Cr 764.6Cr 11Cr 76Cr 30Cr 368.56Cr 30Cr 29Cr 1.28TCr 74Cr 11Cr 9.51Cr 8.77Cr 8.22Cr 15Cr 1.05TCr 16Cr 104.62Cr 41Cr 506.02Cr 41Cr 40Cr 1.76TCr
Net Debt - -
Logo Qingdao Baheal Medical INC.
Qingdao Baheal Medical Inc is a China-based company primarily engaged in the wholesale, distribution retail and brand operations of pharmaceutical. The Company operates through three segments. The Branded Product Sales and Promotion segment is primarily engaged in the sales and distribution of various branded products. The Pharmaceutical Wholesale and Distribution segment is primarily engaged in pharmaceutical logistics and distribution, wholesales and distributes pharmaceuticals, medical devices and consumables to hospitals, community clinics and pharmacies. The Pharmaceutical and Health Products Retail segment sells pharmaceuticals and other health products directly to consumers through a combination of offline pharmacies and various online channels. The Company primarily operates in domestic and international markets.
Employees
2,493
Date Price Change Volume
11/26/11 19.96 ¥ -2.30% 28,63,243
10/26/10 20.43 ¥ +1.14% 34,28,046
09/26/09 20.20 ¥ -0.74% 28,93,400
08/26/08 20.35 ¥ -3.46% 39,31,820
05/26/05 21.08 ¥ +1.69% 45,40,200
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
19.96CNY
Average target price
27.31CNY
Spread / Average Target
+36.82%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 301015 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!